Abstract:In their normal in vivo matrix milieu, tissues assume complex well-organized 3D architectures. Therefore, a primary aim in the tissue engineering design process is to fabricate an optimal analog of the in vivo scenario, in which the precise configuration and composition of cells and bioactive matrix components can establish the well-defined biomimetic microenvironments that promote cell-cell and cell-matrix interactions. With the advent and refinements in microfabricated systems which can present physical and chemical cues to cells in a controllable and reproducible fashion unrealizable with conventional tissue culture, high-fidelity, high-throughput in vitro models are achieved. The convergence of solid freeform fabrication (SFF) technologies, namely microprinting, along with microfabrication techniques, a 3D microprinted micro-organ, can serve as an in vitro platform for cell culture, drug screening, or to elicit further biological insights. This chapter firstly details the principles, methods, and applications that undergird the fabrication process development and adaptation of microfluidic devices for the creation of a drug screening model. This model involves the combinatorial setup of an automated syringe-based, layered direct cell writing microprinting process with soft lithographic micropatterning techniques to fabricate a microscale in vitro device housing a chamber of microprinted 3D micro-organ that biomimics the cell's natural microenvironment for enhanced performance and functionality. In order to assess the structural formability and biological feasibility of such a micro-organ, 3D cell-encapsulated hydrogel-based tissue constructs are microprinted reproducibly in defined design patterns and biologically characterized for both viability and cell-specific function. Another key facet of the in vivo microenvironment that is recapitulated with the in vitro system is the necessary dynamic perfusion of the 3D microscale liver analog with cells probed for their collective drug metabolic function and suitability as a drug metabolism model.

Fabrication Of Micro Organs Using A Digital Micro-Mirroring Microfabrication System

A Digital Micro-Mirror Device-Based System for the Fabrication of Microfluidic Tissue Array

Fabrication of Biological Microfluidics Using A Digital Microfabrication System

A Digital Manufactured Microfluidic Platform for Flexible Construction of 3D Co-Culture Tumor Model with Spatiotemporal Resolution

3D micro/nano fabrication and its application in cancer biophysics

Nano‐ and Microfabrication for Engineering Native‐Like Muscle Tissues

A Microfluidic Platform for Multi-Size 3D Tumor Culture, Monitoring and Drug Resistance Testing

Microscale Tissue Engineering and the Bottom-up Assembly for 3D Tissue Construction

Microfluidics‐Molded Through‐Hole Membranes for 3D Culture Array‐Based Tumor Manipulation and Analysis

Microrobotic Assembly of Shape-Controllable Microstructures to Perfusable 3D Cell-Laden Microtissues

Computer-Aided Design, Modeling, and Freeform Fabrication of 3D Tissue Constructs for Drug Metabolism Studies

3D Tumor Model Biofabrication

Microrobotic Assembly of Cellular Micromodules into 3 D Microtissues Mimicking in Vivo Structures

Microprinting of liver micro-organ for drug metabolism study.

Microfabrication-Based Three-Dimensional (3-D) Extracellular Matrix Microenvironments for Cancer and Other Diseases

Microfluidics for Cancer Nanomedicine: From Fabrication to Evaluation

Rapid Tissue Prototyping with Micro-Organospheres.

Fabrication of Paper-Based Devices for in Vitro Tissue Modeling

Maskless fabrication of cell-laden microfluidic chips with localized surface functionalization for the co-culture of cancer cells.

Low-cost Rapid Prototyping and Assembly of an Open Microfluidic Device for a 3D Vascularized Organ-on-a-chip.

Multifunctional Regulation of 3D Cell-Laden Microsphere Culture on an Integrated Microfluidic Device